Biostar Pharmaceuticals (NASDAQ:BSPM) : Traders are bullish on Biostar Pharmaceuticals (NASDAQ:BSPM) as it has outperformed the S&P 500 by a wide margin of 16.77% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 6.4%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 7.76% in the last 1 week, and is up 18.65% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have dropped -32.55% from its 1 Year high price. On Jul 13, 2015, the shares registered one year high at $7.21 and the one year low was seen on May 19, 2016. The 50-Day Moving Average price is $3.31 and the 200 Day Moving Average price is recorded at $2.37.
The stock has recorded a 20-day Moving Average of 3.39% and the 50-Day Moving Average is 76.44%.
Biostar Pharmaceuticals (NASDAQ:BSPM): On Fridays trading session , Opening price of the stock was $5.1 with an intraday high of $5.33. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $4.5. However, the stock managed to close at $4.58, a loss of 8.40% for the day. On the previous day, the stock had closed at $5. The total traded volume of the day was 1,739,485 shares.
Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company through its wholly owned subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar) and its variable interest entities (VIEs) Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan) develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the Peoples Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company also offers Hernia Belt, a medical device used for the treatment of Hernia. The Companys products are derived from medicinal herbs that are either grown at its own facility or purchased from its suppliers. The Companys products are sold in around 28 provinces in the PRC through a network of around 63 distributors and 226 sales people.